Liver-specific glucose-6-phosphatase is not present in human placenta

J Inherit Metab Dis. 1985;8(2):92-4. doi: 10.1007/BF01801675.

Abstract

Type I glycogen storage disease (McKusick 23220), an inherited absence or deficiency of glucose-6-phosphatase (EC 3.1.3.9) activity in the liver, kidney and intestine, is associated with the accumulation of glycogen in those organs. Previous reports have shown that glucose-6-phosphatase exists in human placenta and that detection of a heterozygote for this disorder from placenta might be possible. Our finding of a normal glucose-6-phosphatase activity in a placenta from a patient at risk for type Ia glycogen storage disease prompted us to examine in more detail placental glucose-6-phosphatase. Unexpectedly, we found the properties of the placental enzyme differed from that in normal liver, and the placental enzyme hydrolyzed glucose-6-phosphate, mannose-6-phosphate, beta-glycerol phosphate and glucose-1-phosphate equally well. Our data suggest the enzyme deficient in type I glycogen storage disease cannot be detected in placenta.

MeSH terms

  • Female
  • Fetal Diseases / diagnosis
  • Glucose-6-Phosphatase / analysis*
  • Glucose-6-Phosphatase / isolation & purification
  • Glycogen Storage Disease Type I / diagnosis
  • Glycogen Storage Disease Type I / genetics*
  • Humans
  • Liver / enzymology*
  • Placenta / enzymology*
  • Pregnancy
  • Prenatal Diagnosis

Substances

  • Glucose-6-Phosphatase